Ori Gutwerg
SVP, GENERICS · ANI PHARMACEUTICALS INC
IndividualSelling only
- 2025
- Aug 12, 2026
- 9
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Ori Gutwerg files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Nikhil Lalwani - $5.05M in ANIP purchases and sales in the last 12 months
- Patrick D. Walsh - $2.32M in ANIP purchases and sales in the last 12 months
- Stephen P. Carey - $1.99M in ANIP purchases and sales in the last 12 months
- Christopher Mutz - $1.64M in ANIP purchases and sales in the last 12 months
- Chad Gassert - $1.31M in ANIP purchases and sales in the last 12 months
- Krista Davis - $785K in ANIP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Ori Gutwerg?
Ori Gutwerg is a corporate insider, tracked as SVP, GENERICS of ANI PHARMACEUTICALS INC (ANIP). InsiderAlpha holds 9 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Ori Gutwerg submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Ori Gutwerg been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($1.18M) across all tracked filings.
